Family Medicine · Rio Grande City, TX
NPI
1275846156
Since 2010
Specialty
Family Medicine
Code 207Q00000X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
2768 Pharmacy Rd
Rio Grande City, TX, 78582
Phone (956) 487-5621
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,124 services
Medicare patients, 2024
184
Average age 73
Drug cost, 2024
$2.7M
33,176 prescriptions
Company payments, 2025
$50.13
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mario L Vasquez Aguilar was code 99214 (office e&m - established), 249 times for 66 patients. In total Mario L Vasquez Aguilar billed 1,124 services in 40 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 249 | 66 | $83.16 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 210 | 46 | $89.84 | $19K |
| 36415 Venipuncture Blood Collection | Office | 119 | 64 | $8.58 | $1,021 |
| 99223 Hospital E&M - Initial | Facility | 74 | 45 | $130.85 | $9,683 |
| 99239 Hospital Discharge Management | Facility | 69 | 44 | $86.71 | $5,983 |
| 81002 Clinical Chemistry | Office | 65 | 28 | $3.41 | $222 |
| 85025 Blood Count | Office | 63 | 28 | $7.61 | $479 |
| 99308 SNF E&M | Office | 61 | 19 | $56.59 | $3,452 |
| 99204 Office E&M - New | Office | 28 | 28 | $126.25 | $3,535 |
| 99213 Office E&M - Established | Office | 27 | 18 | $61.48 | $1,660 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 17 | 14 | $0.33 | $5.64 |
| 96372 Injection Administration | Office | 17 | 15 | $10.84 | $184 |
By year: 2022 $80K for 1,363 services; 2023 $73K for 1,332 services; 2024 $69K for 1,124 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 119 | 64 | $8.58 | $1,021 |
| 81002 Clinical Chemistry | 65 | 28 | $3.41 | $222 |
| 85025 Blood Count | 63 | 28 | $7.61 | $479 |
Medicare prescription drug claims, 2024
In 2024, the drug Mario L Vasquez Aguilar prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,483 prescriptions and refills. In total Mario L Vasquez Aguilar wrote 33,176 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,483 | 3,475 | 433 | $16K |
| Alprazolam Generic | 1,305 | 1,310 | 253 | $6,967 |
| Pantoprazole Sodium Generic | 949 | 2,073 | 287 | $16K |
| Tramadol Hcl Generic | 921 | 925 | 219 | $5,218 |
| Levothyroxine Sodium Generic | 770 | 1,521 | 175 | $8,296 |
| Amlodipine Besylate Generic | 767 | 1,878 | 217 | $6,675 |
| Clopidogrel Clopidogrel Bisulfate | 641 | 1,251 | 145 | $7,036 |
| Gabapentin Generic | 640 | 817 | 152 | $6,600 |
| Memantine Hcl Generic | 605 | 890 | 92 | $13K |
| Tamsulosin Hcl Generic | 576 | 1,203 | 145 | $8,586 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 546 | 546 | 137 | $7,191 |
| Metformin Hcl Generic | 537 | 1,310 | 168 | $4,584 |
| Allopurinol Generic | 536 | 1,196 | 136 | $4,892 |
| Losartan Potassium Generic | 519 | 1,202 | 159 | $5,338 |
| Donepezil Hcl Generic | 495 | 724 | 68 | $5,135 |
Brand drugs: 4,235 claims; generic drugs: 28,564 claims; opioid claims: 1,750.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mario L Vasquez Aguilar $50.13 ($50.13 in general payments such as food, travel and fees) from 2 companies. The largest payer was Lilly USA, LLC with $29.72.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 1 | $29.72 |
| Phadia US Inc. | 1 | $20.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.